Fairvalue-Calculator Fairvalue-Calculator
EN DE

Vivozon Pharmaceutical Co (082800) Fair Value & Analysis

Healthcare · KR · Market cap 236B KRW

Price2,720 KRW
Fair Value2,928 KRW
Upside+7.6%
Quality95/100
Evidence: Low Range 2,196 KRW – 3,660 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Vivozon Pharmaceutical Co (082800) currently trades at 2,720 KRW, while our model-based Fair Value estimate is 2,928 KRW — implying the stock looks roughly 7.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots. In addition, the company operates Echo House, a lighting show room that sells LED florescent lamps, LED flat lamps, LED PAR lamps, LED bulb lamps, and home LED lightings. The company was formerly known as Vivozon Healthcare, Inc. and changed its name to Vivozon Pharmaceutical Co., Ltd. in November 2022. Vivozon Pharmaceutical Co., Ltd. was founded in 2002 and is based in Yongin, South Korea.

Open the full interactive analysis →

Similar stocks

ST Pharm Co (237690) -47% NatureCell Co (007390) -75% Oscotec Inc (039200) -8% DongKook Pharmaceutical Co (086450) +7% Kolon Life Science Inc (102940) -15% Komipharm International Co (041960) -88%

Frequently asked questions

Is Vivozon Pharmaceutical Co (082800) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 2,928 KRW versus a price of 2,720 KRW — about +8% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 082800?
Our 21-model fair value for Vivozon Pharmaceutical Co is 2,928 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 2,720 KRW.
What is the quality score of 082800?
Vivozon Pharmaceutical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.